<p data-path-to-node="2"><b data-path-to-node="2" data-index-in-node="0">DOHA</b> — In response to soaring global demand for temperature-sensitive medical shipments, life-saving vaccines, and biopharmaceutical payloads, Qatar Airways Cargo has officially announced a strategic expansion of its main-deck capacity dedicated to pharmaceutical logistics.</p><p data-path-to-node="3">The initiative leverages the carrier’s advanced widebody freighter fleet and state-of-the-art hub facilities at Hamad International Airport to support seamless cold-chain transitions. By enhancing main-deck allocation for active and passive temperature-controlled containers, Qatar Airways Cargo aims to eliminate transit bottlenecks, protect critical medical integrity during extreme seasonal temperature peaks, and reinforce its dominant position across high-value global health corridors.</p><p data-path-to-node="4">Industry logistics managers note that this strategic capacity boost provides vital stability for global healthcare supply chains, ensuring uninterrupted cold-chain assurance on high-volume lanes connecting Asia, the Middle East, Europe, and the Americas.</p>